Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interstitial Lung Disease Exacerbations Study

NCT06685874 is registered in ClinicalTrials.gov with Royal Devon and Exeter NHS Foundation Trust as lead sponsor.

NCT NCT06685874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06685874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interstitial Lung Disease Exacerbations Study
Lead sponsor
Royal Devon and Exeter NHS Foundation Trust
Phase
Observational
Overall status
Active, not recruiting
Start date
May 1, 2025
Completion date
August 1, 2026
Enrollment
1,500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease (ild), pulmonary fibrosis